Movement Disorders CentreWestern University

Research Funding for MDC



In addition to the grants listed below, the London Movement Disorder Centre has collaborations with various industry partners to advance therapies for the treatment of neurological disorders. Having conducted more than 40 industry-sponsored clinical trials, the LondonMDC also actively conducts investigator-initiated trials that are designed by Dr. Jog and his clinical team. In recent years, these investigator studies have been generously supported by peer-reviewed industry grants from Allergan, Abbvie, Boston Scientific, Medtronic, Merz Pharma, Teva, and many others.

2017-2020       Treatment of Parkinson using a novel neuromodulating drug
                        (Mitacs Accelerate - Industry Matched)

2017-2020       DBS in Parkinson’s patients monitored by whole-body kinematics
                        (Mitacs Accelerate - Industry Matched)

2013-2020       Graduate Researcher Scholarship Fund (Let’s Shake Charity - Kim Petrie)

2017-2019       Treatment of Parkinson Tremor in the Upper Limb 
                        (TalentEdge OCE - Industry Matched)

2017-2019       Optimizing Current Steering DBS in Parkinson’s Patients
                        (TalentEdge OCE - Industry Matched)

2017-2019       Quantitative Analysis of Parkinson’s Disease Symptoms
                        (SOSCIP IBM - Industry Matched)

2017-2018       Treatment for Parkinson's Mobility
                        (Parkinson Society Southwestern Ontario)

2015-2018       Rehabilitation of Parkinson Disease patients using sensor technologies 
                         and robotic haptic feedback
                        (AGE-WELL NCE)

2014-2018       Comparison of clinical and kinematic assessment in the determination of botulinum
                       injection parameters in patients with torticollis 
                      (Mitacs Accelerate - Industry Matched)

2014-2018       Ontario Neurodegenerative Disease Research Initiative
                        (Ontario Brain Institute)

2014-2018       Botulinum toxin type A for injection of bilateral upper extremity tremor in patients 
                         with Essential Tremor using kinematic assessment 
                        (Mitacs Accelerate - Industry Matched)

2015-2018       DBS Brain Radio long-term monitoring of Parkinson's Patients 
                        (CIHR - Industry Matched)

2015-2017      Parkinson Disease monitoring using wearable sensors following surgery 
                        and other medical interventions
                        (Lawson Strategic Research Fund)